Recombinant multi-species FABP3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FABP3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The intracellular fatty acid-binding proteins (FABPs) belongs to a multigene family. FABPs are divided into at least three distinct types, namely the hepatic-, intestinal- and cardiac-type. They form 14-15 kDa proteins and are thought to participate in the uptake, intracellular metabolism and/or transport of long-chain fatty acids. They may also be responsible in the modulation of cell growth and proliferation. Fatty acid-binding protein 3 gene contains four exons and its function is to arrest growth of mammary epithelial cells. This gene is a candidate tumor suppressor gene for human breast cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
The Alternative Names of target: FABP,FABP-3,FABP11,FABP3,Fabp3,Fabph-1,Fabph-4,Fabph1,Fabph4,Fatty acid-binding protein,Fatty acid-binding protein 3,H-FABP,Heart-type fatty acid-binding protein (H-FABP),M-FABP,MDGI,Mammary-derived growth inhibitor (MDGI),Mdgi,Muscle fatty acid-binding protein (M-FABP),O-FABP,heart

Target products collectionGo to FABP3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2483-Ag-1/ GM-Tg-hg-IP2483-Ag-2 Human FABP3 protein Human
GM-Tg-rg-IP2483-Ag-1/ GM-Tg-rg-IP2483-Ag-2 Rat FABP3 protein Rat
GM-Tg-mg-IP2483-Ag-1/ GM-Tg-mg-IP2483-Ag-2 Mouse FABP3 protein Mouse
GM-Tg-cynog-IP2483-Ag-1/ GM-Tg-cynog-IP2483-Ag-2 Cynomolgus/Rhesus macaque FABP3 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2483-Ag-1/ GM-Tg-felg-IP2483-Ag-2 Feline FABP3 protein Feline
GM-Tg-cang-IP2483-Ag-1/ GM-Tg-cang-IP2483-Ag-2 Canine FABP3 protein Canine
GM-Tg-bovg-IP2483-Ag-1/ GM-Tg-bovg-IP2483-Ag-2 Bovine FABP3 protein Bovine
GM-Tg-equg-IP2483-Ag-1/ GM-Tg-equg-IP2483-Ag-2 Equine FABP3 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2483-Ag-1/ GM-Tg-hg-IP2483-Ag-2; GM-Tg-rg-IP2483-Ag-1/ GM-Tg-rg-IP2483-Ag-2;
GM-Tg-mg-IP2483-Ag-1/ GM-Tg-mg-IP2483-Ag-2; GM-Tg-cynog-IP2483-Ag-1/ GM-Tg-cynog-IP2483-Ag-2;
GM-Tg-felg-IP2483-Ag-1/ GM-Tg-felg-IP2483-Ag-2; GM-Tg-cang-IP2483-Ag-1/ GM-Tg-cang-IP2483-Ag-2;
GM-Tg-bovg-IP2483-Ag-1/ GM-Tg-bovg-IP2483-Ag-2; GM-Tg-equg-IP2483-Ag-1/ GM-Tg-equg-IP2483-Ag-2
Products Name FABP3 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name FABP3
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FABP3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.